{"DataElement":{"publicId":"3588591","version":"3","preferredName":"Disease or Disorder Hematologic Status Leukemia Status Type","preferredDefinition":"A description of the hematologic disease status of leukemia.","longName":"3588590v1.0:3072087v1.3","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3588590","version":"1","preferredName":"Disease or Disorder Hematologic Status","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Pertaining to or related to the blood and blood-forming organs._A condition or state at a particular time.","longName":"2404658v1.0:2933413v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2933413","version":"1","preferredName":"Hematologic Status","preferredDefinition":"Pertaining to or related to the blood and blood-forming organs.:A condition or state at a particular time.","longName":"C62780:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematologic","conceptCode":"C62780","definition":"Pertaining to or related to the blood and blood-forming organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7159A552-B79D-44C1-E040-BB89AD430610","latestVersionIndicator":"Yes","beginDate":"2009-08-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2009-08-17","modifiedBy":"ONEDATA","dateModified":"2009-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C9703EAF-77ED-41B3-E040-BB89AD432454","latestVersionIndicator":"Yes","beginDate":"2012-09-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-09-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3072087","version":"1.3","preferredName":"Leukemia Status Type","preferredDefinition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years._A condition or state at a particular time._Type; a subdivision of a particular kind of thing.","longName":"3072087v1.3","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1st complete remission","valueDescription":"Complete Response, Preliminary","ValueMeaning":{"publicId":"2770751","version":"1","preferredName":"Complete Response, Preliminary","longName":"2770751","preferredDefinition":"Preceding all others in time or space or degree.: The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53E0F58A-823C-509B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-08-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":"User curated long name to support DCI, Modified RANO, ghd, 04.24.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E8E0E-3678-7D40-E050-BB89AD4378C7","beginDate":"2010-04-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-11-20","modifiedBy":"ONEDATA","dateModified":"2014-11-20","deletedIndicator":"No"},{"value":"No treatment","valueDescription":"Negation Therapeutic Procedure","ValueMeaning":{"publicId":"3308097","version":"1","preferredName":"Negation Therapeutic Procedure","longName":"3308097","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2045A13-8290-ADB5-E040-BB89AD4374D9","latestVersionIndicator":"Yes","beginDate":"2011-11-18","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-11-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E8E0E-36FC-7D40-E050-BB89AD4378C7","beginDate":"2014-11-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-11-20","modifiedBy":"ONEDATA","dateModified":"2014-11-20","deletedIndicator":"No"},{"value":"1st relapse","valueDescription":"First Recurrent Disease","ValueMeaning":{"publicId":"2769848","version":"1","preferredName":"First Recurrent Disease","longName":"2769848","preferredDefinition":"Preceding all others in time or space or degree.: the return of a sign, symptom, or disease after a remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53A199B4-7362-3A66-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E8E0E-3696-7D40-E050-BB89AD4378C7","beginDate":"2010-04-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-11-20","modifiedBy":"ONEDATA","dateModified":"2014-11-20","deletedIndicator":"No"},{"value":"2nd complete remission","valueDescription":"Second Complete Remission","ValueMeaning":{"publicId":"2769849","version":"1","preferredName":"Second Complete Remission","longName":"2769849","preferredDefinition":"Coming next after the first in position in space or time or degree or magnitude.: The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Second","conceptCode":"C25666","definition":"Coming next after the first in position in space or time or degree or magnitude.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53A199B4-738A-3A66-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E8E0E-36A0-7D40-E050-BB89AD4378C7","beginDate":"2010-04-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-11-20","modifiedBy":"ONEDATA","dateModified":"2014-11-20","deletedIndicator":"No"},{"value":"2nd relapse","valueDescription":"Second Recurrent Disease","ValueMeaning":{"publicId":"2769850","version":"1","preferredName":"Second Recurrent Disease","longName":"2769850","preferredDefinition":"Coming next after the first in position in space or time or degree or magnitude.: the return of a sign, symptom, or disease after a remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Second","conceptCode":"C25666","definition":"Coming next after the first in position in space or time or degree or magnitude.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53A199B4-73AF-3A66-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E8E0E-36AA-7D40-E050-BB89AD4378C7","beginDate":"2010-04-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-11-20","modifiedBy":"ONEDATA","dateModified":"2014-11-20","deletedIndicator":"No"},{"value":">= 3rd complete remission","valueDescription":"Greater Than or Equal To Integer::3 Complete Remission","ValueMeaning":{"publicId":"3072089","version":"1","preferredName":"Greater Than or Equal To Integer::3 Complete Remission","longName":"3072089","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.: A number with no fractional part.::3: The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than or Equal To","conceptCode":"C61583","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84B2D65C-DEFD-69FB-E040-BB89AD432401","latestVersionIndicator":"Yes","beginDate":"2010-04-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-04-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E8E0E-36B4-7D40-E050-BB89AD4378C7","beginDate":"2010-04-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-11-20","modifiedBy":"ONEDATA","dateModified":"2014-11-20","deletedIndicator":"No"},{"value":">= 3rd relapse","valueDescription":"Greater Than or Equal To Integer::3 Recurrent Disease","ValueMeaning":{"publicId":"3053622","version":"1","preferredName":"Greater Than or Equal To Integer::3 Recurrent Disease","longName":"3053622","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.: A number with no fractional part.::3: the return of a sign, symptom, or disease after a remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than or Equal To","conceptCode":"C61583","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83970E6A-72A1-0B56-E040-BB89AD435258","latestVersionIndicator":"Yes","beginDate":"2010-04-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-04-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E8E0E-36BE-7D40-E050-BB89AD4378C7","beginDate":"2010-04-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-11-20","modifiedBy":"ONEDATA","dateModified":"2014-11-20","deletedIndicator":"No"},{"value":"Primary induction failure","valueDescription":"Primary Induction Failure","ValueMeaning":{"publicId":"3072088","version":"1","preferredName":"Primary Induction Failure","longName":"3072088","preferredDefinition":"A disease status whereby the patient does not achieve a complete remission. It may not be limited to the first/initial course of therapy; it may represent all courses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Induction Failure","conceptCode":"C70622","definition":"A disease status whereby the patient does not achieve a complete remission. It may not be limited to the first/initial course of therapy; it may represent all courses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84B2D65C-DED6-69FB-E040-BB89AD432401","latestVersionIndicator":"Yes","beginDate":"2010-04-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-04-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08A0C7FE-BB42-A6A5-E050-BB89AD435B6F","beginDate":"2010-04-20","endDate":null,"createdBy":"NYCHM","dateCreated":"2014-11-24","modifiedBy":"ONEDATA","dateModified":"2014-11-24","deletedIndicator":"No"},{"value":"Currently undergoing induction treatment","valueDescription":"Currently Receiving Induction Therapy","ValueMeaning":{"publicId":"7144096","version":"1","preferredName":"Currently Receiving Induction Therapy","longName":"7144096","preferredDefinition":"An indication that an individual is receiving something at the present time.: The first choice of treatment for a particular type of cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Currently Receiving","conceptCode":"C159274","definition":"An indication that an individual is receiving something at the present time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Induction Therapy","conceptCode":"C158876","definition":"The first choice of treatment for a particular type of cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C54E484-1CB3-273D-E053-F662850A2D07","latestVersionIndicator":"Yes","beginDate":"2020-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C54E484-1CCC-273D-E053-F662850A2D07","beginDate":"2020-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-01-17","modifiedBy":"ONEDATA","dateModified":"2020-01-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3286970","version":"1","preferredName":"Leukemia Status Type","preferredDefinition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.:A condition or state at a particular time.:Type; a subdivision of a particular kind of thing.","longName":"C3161:C25688:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE01C0F2-D5EF-36FA-E040-BB89AD430F82","latestVersionIndicator":"Yes","beginDate":"2011-09-28","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-28","modifiedBy":"ONEDATA","dateModified":"2011-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"084E8E0E-3661-7D40-E050-BB89AD4378C7","latestVersionIndicator":"Yes","beginDate":"2014-11-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-11-20","modifiedBy":"KUMMEROA","dateModified":"2020-01-17","changeDescription":". Added PV for 2532. AK 2020-1-17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964927","version":"1","longName":"2010r1: Acute Myelogenous Leukemia Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964928","version":"1","longName":"2011r1: ALL Pre-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"ALLpre_dis_stat_prep_dis_hematolog_stat","type":"NMDP_FN","context":"NHLBI"},{"name":"AMLpre_dis_stat_prep_dis_hematolog_stat","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedDiagnosis:diseaseStatusCode","type":"HCT_BRIDG","context":"NHLBI"},{"name":"PreTed_prime_dis_hct_all_dis_hematolog_stat","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_prime_dis_hct_aml_dis_hematolog_stat","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_prime_dis_hct_oth_lk_dis_hematolog_stat","type":"NMDP_FN","context":"NHLBI"},{"name":"all_base_prep_st_lst_eval","type":"NMDP_FN","context":"NHLBI"},{"name":"aml_base_prep_dx_status","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_ALL_dis_hematolog_stat","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_ALMN_dis_hematolog_stat","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_AML_dis_hematolog_stat","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the hematologic dise","type":"Preferred Question Text","description":"What was the hematologic disease status of the leukemia?","url":null,"context":"NHLBI"},{"name":"What was the disease status based on hematological test results?","type":"Alternate Question Text","description":"What was the disease status based on hematological test results?","url":null,"context":"NHLBI"},{"name":"What was the disease status (based on hematologic test results)?","type":"Application Standard Question Text","description":"What was the disease status (based on hematologic test results)?","url":null,"context":"NHLBI"},{"name":"What was the disease status?","type":"Alternate Question Text","description":"What was the disease status?","url":null,"context":"NHLBI"},{"name":"BRIDG Mapping for CDE:3588591","type":"BRIDG Mapping Path","description":"\"PerformedDiagnosis.diseaseStatusCode WHERE PerformedDiagnosis.value = \"\"acute myologenous leukemia(AML)\"\" OR \"\"acute nonlymphocytic leukemia\"\" AND PerformedDiagnosis.reportedDate IS LESS THAN OR EQUAL TO PerformedSubstanceAdministration.dateRange AND PerformedSubstanceAdministration > DefinedSubstanceAdministration.nameCode = \"\"Administer Hematopoietic Cell Product{ Transplantation}\"\"\"","url":null,"context":"NHLBI"},{"name":"BRIDG Mapping for CDE 3588591","type":"BRIDG Mapping Path","description":"\"PerformedDiagnosis.diseaseStatusCode  WHERE PerformedDiagnosis.value = \"\"Acute Lymphoblastic Leukemia(ALL)\"\" AND PerformedDiagnosis.reportedDate IS LESS THAN OR EQUAL TO PerformedSubstanceAdministration.dateRange AND PerformedSubstanceAdministration > DefinedSubstanceAdministration.nameCode = \"\"Administer Hematopoietic Cell Product{ Transplantation}\"\"\"","url":null,"context":"NHLBI"},{"name":"What is the current disease status (based on hematological test results)?","type":"Alternate Question Text","description":"What is the current disease status (based on hematological test results)?","url":null,"context":"NHLBI"},{"name":"What is the current disease status (based on hematological test results)? (AML and ALL)","type":"Alternate Question Text","description":"What is the current disease status (based on hematological test results)? (AML and ALL)","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"084E8E0E-370A-7D40-E050-BB89AD4378C7","latestVersionIndicator":"Yes","beginDate":"2014-11-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-11-20","modifiedBy":"ALEYR","dateModified":"2019-04-13","changeDescription":".Added AQT. 04/09/2019 KMM. Added AQT. 04/10/2019 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}